HIV/AIDS-Associated Kaposi Sarcoma
Generic HAART reduces viral load to undetectable in AIDS-associated KS patients
Published in TB and Outbreaks Week, June 21st, 2005
According to a study from South Africa, "Generic antiretroviral drugs are pivotal in the implementation of WHO's '3 by 5' program. However, clinical experience with generics in sub-Saharan Africa is insufficiently documented.
"We report on 50 patients with HIV-associated Kaposi's sarcoma treated with generic fixed-dose highly active antiretroviral therapy."
"At 52 weeks, 74% achieved an undetectable viral load of <50 copies/ml, 86% achieved <400 copies/ml, and a 3.1 log10 decline from baseline. Side effects were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Coronavirus Outbreaks
Human coronavirus OC43 caused influenza-like illness in aged-care facilities - Pulmonary Tuberculosis
NRAMP1 gene variants associated with severe forms of pulmonary tuberculosis - SARS
SARS outbreak correlates with environmental temperature 7 days before onset - SARS Coronavirus
Phylogenetic method analyzes SARS-CoV sources and dissemination paths - Viral Meningitis
Viral meningitis outbreak associated with public swimming pond - Adverse Drug Reaction
Anti-tuberculosis drugs correlate with severe liver toxicity in Spain - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
